VIDEO:

The pandemic has been disastrous, to say nothing of deadly, for the vast majority of us, but that doesn’t mean COVID-19 hasn’t represented a boon for certain sectors. Case in point: Pfizer, which is on pace to see more than $100 billion in additional revenue thanks to the COVID vaccine and Paxlovid, which together have more than doubled Pfizer’s sales figures since early 2020. And with no end to COVID-19 in sight, Pfizer is poised to keep on raking in the billions for treating, but never eradicating, what has turned out to be a very profitable virus for this Big Pharma enterprise.

https://www.youtube.com/watch?v=4k7jmtNjHaU